CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced the appointment of Keith A. Goldan, CPA, as vice president and chief financial officer. This appointment follows the recent announcement that NuPathe raised $30 million in a Series B equity financing in July.
